Search Results

Your search for Peter Paul Yu, MD, FACP, FASCO matches 2 pages

Showing 1 - 2

By The ASCO Post Staff / Monday, June 1, 2015 1:56 PM

ASCO 2015: ASCO Announces First-Ever Clinical Trial

ASCO announced its first-ever clinical trial, which will offer patients with advanced cancer access to molecularly targeted cancer drugs and collect “real-world” data on clinical outcomes, to help learn the best uses of these drugs outside of indications approved by the U.S. Food and...

By Jo Cavallo / Tuesday, January 20, 2015 3:14 PM

ASCO Releases Annual Report on Progress Against Cancer and Names the Cancer Advance of the Year

ASCO released its report, Clinical Cancer Advances 2015: An Annual Report on Progress Against Cancer, today, and for the first time announced its cancer Advance of the Year: gains made in the treatment of chronic lymphocytic leukemia (CLL). ASCO credits the improvements in CLL care with the...

Apr

Today In Oncology

Search Results

Your search for Peter Paul Yu, MD, FACP, FASCO matches 2 pages

ASCO 2015: ASCO Announces First-Ever Clinical Trial

ASCO Releases Annual Report on Progress Against Cancer and Names the Cancer Advance of the Year

FDA Approves Lu-177 Dotatate for Pediatric Patients With GEP-NETs

AI Model May Help Predict Treatment Responses Select Most Effective Cancer Therapies in Patients With Cancer

In-Hospital Mortality Among Patients With COVID-19 Infection, With or Without Cancer

Imaging Drug to Assist in Detection of Cancerous Tissue Following Lumpectomy Approved

Potential Protective Effects of Aspirin Against Colorectal Cancer